Standard

In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes. / Shevchenko, Julia A.; Lopatnikova, Julia A.; Khantakova, Julia N. et al.

In: Frontiers in Bioscience - Landmark, Vol. 27, No. 6, 170, 06.2022.

Research output: Contribution to journalArticlepeer-review

Harvard

Shevchenko, JA, Lopatnikova, JA, Khantakova, JN, Silkov, AN, Kuznetsova, MS, Kurilin, VV, Maksyutov, AZ & Sennikov, SV 2022, 'In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes', Frontiers in Bioscience - Landmark, vol. 27, no. 6, 170. https://doi.org/10.31083/j.fbl2706170

APA

Shevchenko, J. A., Lopatnikova, J. A., Khantakova, J. N., Silkov, A. N., Kuznetsova, M. S., Kurilin, V. V., Maksyutov, A. Z., & Sennikov, S. V. (2022). In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes. Frontiers in Bioscience - Landmark, 27(6), [170]. https://doi.org/10.31083/j.fbl2706170

Vancouver

Shevchenko JA, Lopatnikova JA, Khantakova JN, Silkov AN, Kuznetsova MS, Kurilin VV et al. In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes. Frontiers in Bioscience - Landmark. 2022 Jun;27(6):170. doi: 10.31083/j.fbl2706170

Author

Shevchenko, Julia A. ; Lopatnikova, Julia A. ; Khantakova, Julia N. et al. / In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes. In: Frontiers in Bioscience - Landmark. 2022 ; Vol. 27, No. 6.

BibTeX

@article{2a0f86735ffb463d997a81e6b6575637,
title = "In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes",
abstract = "Background: A search for efficient graft rejection modulation techniques for the promotion of durable engraftment remains to be a matter of close study all over the world. Despite the variety of immunosuppressive drugs, the schemes currently used show a lack of selectivity and have a number of side effects. Here we investigated an approach for the induction of antigen-specific tolerance in a human “stimulator-responder” model in vitro, using dendritic cells (DCs) transfected with designed DNA constructs encoding the stimulator's major histocompatibility complex (MHC) epitopes. Methods: The object of the study is peripheral blood mononuclear cells (PBMCs) from 10 healthy donors. To induce antigen-specific tolerance, personalized DNA constructs were created for five responder-stimulator pairs, based on the sequences of donors' and recipients' MHCs. DNA sequencing was performed to select epitopes for incorporation into genetic constructs. A mixed lymphocyte culture assay was used (i) to assess the proliferative response in both directions for all possible stimulator-responder pairs (90 reactions) and (ii) to assess the tolerogenic properties of the generated transfected DCs (5 reactions). Results: A significant increase in the amounts of FoxP3+ CD4+CD25+ cells and in IL-10 production was shown in culture of donor mononuclear cells after co-cultivation with the responder's dendritic cells transfected with donor-specific plasmids. The tolerogenic cultures generated using tolerogenic DCs transfected with MHC epitopes had a significantly greater ability to inhibit the proliferation of autologous MNCs in response to an allogeneic MHC stimulus. Conclusions: The produced DCs transfected with DNA constructs against HLA stimulating epitopes exhibited tolerogenic properties and may be used to develop antigen-specific tolerance. Thus, we proposed a perspective approach to the induction of antigen-specific tolerance, which should subsequently be studied for use in clinical practice.",
keywords = "alloantigens, DNA constructs, HLA, mediated immune suppression, MHC, mixed lymphocyte culture, T regulatory cells, tolerogenic dendritic cells, Humans, Dendritic Cells/metabolism, Leukocytes, Mononuclear, Epitopes/genetics, Isoantigens/genetics, Immune Tolerance/genetics, T-Lymphocytes, Regulatory",
author = "Shevchenko, {Julia A.} and Lopatnikova, {Julia A.} and Khantakova, {Julia N.} and Silkov, {Alexander N.} and Kuznetsova, {Maria S.} and Kurilin, {Vasiliy V.} and Maksyutov, {Amir Z.} and Sennikov, {Sergey V.}",
note = "Funding Information: The research (MLC, culture work, functional assays) was conducted under the framework of State Assignment № 1021062512015-4 (FGMN-2021-0003). The steps of DNA transduction and HLA-A genotyping were sponsored by the grant of the Russian Science Foundation project no. 21-65-00004, https://rscf.ru/project/21-65-00004/. Publisher Copyright: Copyright: {\textcopyright} 2022 The Author(s)",
year = "2022",
month = jun,
doi = "10.31083/j.fbl2706170",
language = "English",
volume = "27",
journal = "Frontiers in Bioscience - Landmark",
issn = "2768-6701",
publisher = "Frontiers in Bioscience",
number = "6",

}

RIS

TY - JOUR

T1 - In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes

AU - Shevchenko, Julia A.

AU - Lopatnikova, Julia A.

AU - Khantakova, Julia N.

AU - Silkov, Alexander N.

AU - Kuznetsova, Maria S.

AU - Kurilin, Vasiliy V.

AU - Maksyutov, Amir Z.

AU - Sennikov, Sergey V.

N1 - Funding Information: The research (MLC, culture work, functional assays) was conducted under the framework of State Assignment № 1021062512015-4 (FGMN-2021-0003). The steps of DNA transduction and HLA-A genotyping were sponsored by the grant of the Russian Science Foundation project no. 21-65-00004, https://rscf.ru/project/21-65-00004/. Publisher Copyright: Copyright: © 2022 The Author(s)

PY - 2022/6

Y1 - 2022/6

N2 - Background: A search for efficient graft rejection modulation techniques for the promotion of durable engraftment remains to be a matter of close study all over the world. Despite the variety of immunosuppressive drugs, the schemes currently used show a lack of selectivity and have a number of side effects. Here we investigated an approach for the induction of antigen-specific tolerance in a human “stimulator-responder” model in vitro, using dendritic cells (DCs) transfected with designed DNA constructs encoding the stimulator's major histocompatibility complex (MHC) epitopes. Methods: The object of the study is peripheral blood mononuclear cells (PBMCs) from 10 healthy donors. To induce antigen-specific tolerance, personalized DNA constructs were created for five responder-stimulator pairs, based on the sequences of donors' and recipients' MHCs. DNA sequencing was performed to select epitopes for incorporation into genetic constructs. A mixed lymphocyte culture assay was used (i) to assess the proliferative response in both directions for all possible stimulator-responder pairs (90 reactions) and (ii) to assess the tolerogenic properties of the generated transfected DCs (5 reactions). Results: A significant increase in the amounts of FoxP3+ CD4+CD25+ cells and in IL-10 production was shown in culture of donor mononuclear cells after co-cultivation with the responder's dendritic cells transfected with donor-specific plasmids. The tolerogenic cultures generated using tolerogenic DCs transfected with MHC epitopes had a significantly greater ability to inhibit the proliferation of autologous MNCs in response to an allogeneic MHC stimulus. Conclusions: The produced DCs transfected with DNA constructs against HLA stimulating epitopes exhibited tolerogenic properties and may be used to develop antigen-specific tolerance. Thus, we proposed a perspective approach to the induction of antigen-specific tolerance, which should subsequently be studied for use in clinical practice.

AB - Background: A search for efficient graft rejection modulation techniques for the promotion of durable engraftment remains to be a matter of close study all over the world. Despite the variety of immunosuppressive drugs, the schemes currently used show a lack of selectivity and have a number of side effects. Here we investigated an approach for the induction of antigen-specific tolerance in a human “stimulator-responder” model in vitro, using dendritic cells (DCs) transfected with designed DNA constructs encoding the stimulator's major histocompatibility complex (MHC) epitopes. Methods: The object of the study is peripheral blood mononuclear cells (PBMCs) from 10 healthy donors. To induce antigen-specific tolerance, personalized DNA constructs were created for five responder-stimulator pairs, based on the sequences of donors' and recipients' MHCs. DNA sequencing was performed to select epitopes for incorporation into genetic constructs. A mixed lymphocyte culture assay was used (i) to assess the proliferative response in both directions for all possible stimulator-responder pairs (90 reactions) and (ii) to assess the tolerogenic properties of the generated transfected DCs (5 reactions). Results: A significant increase in the amounts of FoxP3+ CD4+CD25+ cells and in IL-10 production was shown in culture of donor mononuclear cells after co-cultivation with the responder's dendritic cells transfected with donor-specific plasmids. The tolerogenic cultures generated using tolerogenic DCs transfected with MHC epitopes had a significantly greater ability to inhibit the proliferation of autologous MNCs in response to an allogeneic MHC stimulus. Conclusions: The produced DCs transfected with DNA constructs against HLA stimulating epitopes exhibited tolerogenic properties and may be used to develop antigen-specific tolerance. Thus, we proposed a perspective approach to the induction of antigen-specific tolerance, which should subsequently be studied for use in clinical practice.

KW - alloantigens

KW - DNA constructs

KW - HLA

KW - mediated immune suppression

KW - MHC

KW - mixed lymphocyte culture

KW - T regulatory cells

KW - tolerogenic dendritic cells

KW - Humans

KW - Dendritic Cells/metabolism

KW - Leukocytes, Mononuclear

KW - Epitopes/genetics

KW - Isoantigens/genetics

KW - Immune Tolerance/genetics

KW - T-Lymphocytes, Regulatory

UR - http://www.scopus.com/inward/record.url?scp=85132936182&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/08acfa01-705a-3cbe-9e21-9e6e35990d50/

U2 - 10.31083/j.fbl2706170

DO - 10.31083/j.fbl2706170

M3 - Article

C2 - 35748246

AN - SCOPUS:85132936182

VL - 27

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 2768-6701

IS - 6

M1 - 170

ER -

ID: 36559089